Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 2 results.

- Journal article
Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study.
Ajani, Jaffer El Hajbi, Farid Cunningham, David Alsina, Maria Thuss-Patience, Peter Scagliotti, Giorgio V Van den Eynde, Marc[UCL] Kim, Sung-Bae Kato, Ken Shen, Lin Li, Liyun Ding, Ningning Shi, Jingwen Barnes, Gisoo Van Cutsem, Eric (2024) ESMO open — Vol. 9, no.1, p. 102202 [1-9] (2024)
- Journal article
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
Raymond, Eric Kulke, Matthew H. Qin, Shukui Yu, Xianjun Schenker, Michael Cubillo, Antonio Lou, Wenhui Tomasek, Jiri Thiis-Evensen, Espen Xu, Jian-Ming Croitoru, Adina E. Khasraw, Mustafa Sedlackova, Eva Borbath, Ivan[UCL] Ruff, Paul Oberstein, Paul E. Ito, Tetsuhide Jia, Liqun Hammel, Pascal Shen, Lin Shrikhande, Shailesh V. Shen, Yali Sufliarsky, Jozef Khan, Gazala N. Morizane, Chigusa Galdy, Salvatore Khosravan, Reza Fernandez, Kathrine C. Rosbrook, Brad Fazio, Nicola (2018) Neuroendocrinology — Vol. 107, no. 3, p. 237-245 (2018)